CLINICAL_TRIALS
trial_result
· 2025-02-03
Clinical Trial Update: Melanoma Patients Immunized with Natural DenDritic Cells [Phase 3]
Summary
Phase 3 trial evaluating immunization of melanoma patients with natural dendritic cells has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radboud University Medical Center | Conditions: Melanoma (Skin) | Phase 3 | Status: COMPLETED